Company Filing History:
Years Active: 2018-2024
Title: Oula Penate Medina: Innovator in Nanotechnology
Introduction
Oula Penate Medina is a prominent inventor based in Kiel, Germany, known for his significant contributions to the field of nanotechnology. With a total of six patents to his name, Medina has focused on developing innovative solutions for medical applications, particularly in cancer detection and treatment.
Latest Patents
One of Medina's latest patents involves the creation of multimodal silica-based nanoparticles. This invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring, and treatment of diseases such as cancer. The nanoparticles come in various diameters, ranging from about 0.1 nm to about 100 nm. They contain a fluorescent compound that exhibits greater brightness and fluorescent quantum yield than the free fluorescent compound. Additionally, these nanoparticles demonstrate high biostability and biocompatibility. To enhance urinary excretion, they may be coated with an organic polymer like poly(ethylene glycol) (PEG). The small size and silica base minimize toxicity when administered in vivo. Furthermore, the nanoparticles can be conjugated to a ligand for targeting specific cell types, such as tumor markers, and may also carry therapeutic agents. They are designed to be detectable through various imaging techniques, including positron emission tomography (PET) and magnetic resonance imaging (MRI), by incorporating radionuclides or paramagnetic ions.
Career Highlights
Throughout his career, Oula Penate Medina has worked with esteemed institutions such as the Sloan Kettering Institute for Cancer Research and Cornell University. His work has significantly advanced the understanding and application of nanotechnology in medicine.
Collaborations
Medina has collaborated with notable colleagues, including Michelle S. Bradbury and Ulrich B. Wiesner, contributing to the advancement of research in his field.
Conclusion
Oula Penate Medina's innovative work in developing multimodal silica-based nanoparticles showcases his commitment to improving medical diagnostics and treatment options. His contributions continue to influence the field of nanotechnology and cancer research.